Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
cGMP Deviations
Defective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance.
Presence of Particulate Matter
Why this is here: It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.
cGMP deviations
Labeling: Incorrect or Missing Lot and/or Expiration date: Individual vials of Dexonto 0.4%, are labeled correctly with the BUD of 12/25/2024,…
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
cGMP deviations
Lack of Assurance of Sterility
Superpotent Drug: Assay/potency result for hydromorphone HCl in the compounded stability lot was higher than specification..
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation…
Subpotent
Subpotent